The newly announced UK budget includes a little bit more for science, ScienceInsider reports.
In Nature this week: genetic analysis of the British population, and more.
More than two dozen Australian research facilities that were facing closure have been funded, Nature News reports.
The increasing number of research papers being published is leading to a quick turnover of the literature, researchers say in a paper posted at ArXiv.
A new JAMA study finds that the benefit of decreased colorectal cancer risk by taking aspirin erodes in people with certain rare variants.
In Nucleic Acids Research this week: software package for calling point mutations in tumor samples, new HLA typing method, and more.
The US National Cancer Institute is planning a new award for staff scientists.
New Scientist examines the pros and cons of germline genome editing in light of a recent call for a moratorium on the procedure.
A research pair looks into the costs and benefits of grant writing.
In PNAS this week: Pseudomonas aeruginosa essential genome, insulinoma sequencing, and more.
The PubPeer organizers tell Vox how their site aims to help fix the problems plaguing the scientific peer-review process.
Technology Review takes a look at Peter Thiel's approach to biotech investment.
Steven Ashby is to be the new director of the Pacific Northwest National Laboratory.
In PLOS this week: region linked to classic bladder exstrophy, microRNA profiles in depression, and more.
Researchers plan to sequence some 100,000 people of South Asian descent living in London, the Guardian reports.
Genetic testing company 23andMe is opening a new therapeutics group.
In Science this week: genomic determinants of response to immune checkpoint inhibitors, and more.
A study appearing in the New England Journal of Medicine finds that only a small portion of clinical trials are reporting their data in a timely fashion, and poll.
Ewen Callaway at Nature News discusses the difficulties of determining how often mutations appear in the human genome.
Edward Hockings and Lewis Coyne raise concerns in the Guardian regarding the UK's 100,000 Genomes Project and participant privacy.
In Nature this week: genome editing warning, new susceptibility loci for breast cancer, and more.
The US National Science Foundation tries to address issues brought up by lawmakers.
Genetic study of familial hypercholesterolemia implicates link between type 2 diabetes risk and cholesterol transport.
The 100,000 Genomes Project begins to uncover disease mutations.
In Cell this week: gene knockout screen of lung cancer, single-molecule imaging method, and more.
Lauren Celano at Nature Jobs describes the differences between the resume and the CV.
A postdoc position is supposed to be a 'stepping stone,' Nature Jobs says.
Finding a job in the sciences can be a challenge, writes Bryan Gaensler at the Conversation.
Graduate students in India are protesting their low pay.